Matches in Nanopublications for { ?s ?p "[Collectively, the data suggest that the human mAb 1F5, which has recently entered clinical development under the name CDX-1127, may provide direct antitumor activity against CD27-expressing lymphoma or leukemia, independent of its potential to enhance immunity through its agonistic properties.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP515730.RAclK3PKWe300qY9AnGnOd3mkLlX7FichsBEVY93uJX0U130_assertion description "[Collectively, the data suggest that the human mAb 1F5, which has recently entered clinical development under the name CDX-1127, may provide direct antitumor activity against CD27-expressing lymphoma or leukemia, independent of its potential to enhance immunity through its agonistic properties.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP515730.RAclK3PKWe300qY9AnGnOd3mkLlX7FichsBEVY93uJX0U130_provenance.
- NP571801.RAzNMQmzNln7-8Q0zBZgGdKJb_kn-BiZxkD5yLMDcV8xA130_assertion description "[Collectively, the data suggest that the human mAb 1F5, which has recently entered clinical development under the name CDX-1127, may provide direct antitumor activity against CD27-expressing lymphoma or leukemia, independent of its potential to enhance immunity through its agonistic properties.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP571801.RAzNMQmzNln7-8Q0zBZgGdKJb_kn-BiZxkD5yLMDcV8xA130_provenance.
- NP565081.RALDhSnDY_ZeA_yhv4vW-_vD9tOOzAQIKn1aGqH4FjuDw130_assertion description "[Collectively, the data suggest that the human mAb 1F5, which has recently entered clinical development under the name CDX-1127, may provide direct antitumor activity against CD27-expressing lymphoma or leukemia, independent of its potential to enhance immunity through its agonistic properties.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP565081.RALDhSnDY_ZeA_yhv4vW-_vD9tOOzAQIKn1aGqH4FjuDw130_provenance.